Image

Global Auto Injectors Market – Industry Trends and Forecast to 2029

Healthcare

Image

Global Auto Injectors Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Auto Injectors Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 56.01 Billion
Diagram Market Size (Forecast Year) USD 270.78 Billion
Diagram CAGR %

Major Markets Players

  • AbbVie Inc.
  • Mylan N.V.
  • Lily
  • Amgen Inc.
  • Ypsomed Holding

Global Auto Injectors Market, By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies), Type (Disposable Auto injectors, Reusable Auto Injectors), End- User (Home Care Settings, Hospitals and Clinics, Ambulatory Surgical Centers), Route of administration (Subcutaneous, Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Design (Standardized, Customized), Product (Prefilled, Fillable) – Industry Trends and Forecast to 2029.

Auto Injectors Market

Global Auto Injectors Market Analysis and Size

Auto injectors are utilized for epinephrine self-administration in order to prevent anaphylaxis, for immediate pain relief by migraine sufferers and for medical and emergency treatments. The rise in incidence of anaphylaxis is escalating the growth of auto injectors market.

  • The auto injectors market was valued at USD 56.01 billion in 2021 and is expected to reach USD 270.78 billion by 2029, registering a CAGR of 21.77% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Auto Injectors Market Definition

An auto injector refers to a syringe with a spring-charged needle that has a pre-charged dosage of drugs. A measured dosage of a drug is triggered and administered when pressed into the body with a sliding motion. Auto-injectors offer various advantages such as, reducing needle-related phobia disorder, and risks of needle stuck accidents, among others.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies), Type (Disposable Auto injectors, Reusable Auto Injectors), End- User (Home Care Settings, Hospitals and Clinics, Ambulatory Surgical Centers), Route of Administration (Subcutaneous, Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Design (Standardized, Customized), Product (Prefilled, Fillable)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

AbbVie Inc. (US), Mylan N.V. (US), Lily. (US), Amgen Inc. (US), Ypsomed Holding (Switzerland), BD (US), Owen Mumford Ltd. (UK), Consort Medical, Plc. (UK), SHL Medical AG (Switzerland), Johnson Medtech, LLC. (US), Teva Pharmaceuticals USA, Inc. (US), Antares Pharma. (New Jersey), AstraZeneca (UK), Union Medico Inc. (Denmark), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc (US), and Emergent. (US), among others

Auto Injectors Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

  • Prevalence of Targeted Therapies

The increase in the prevalence of targeted therapies, such as alemtuzumab (certain chronic leukemias), and trastuzumab (certain breast cancers), among others acts as one of the major factors driving the growth of auto injectors market.

  • Funds and Grants

The surge in investments in the form of funds and grants for therapies associated with auto injectors accelerate the market growth.

  • Favorable reimbursements

The presence of favorable reimbursements and increasing government support further influence the auto injectors market.

Opportunities

Furthermore, patent expiry of biologics to drive the demand for biosimilars extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, increasing the preference for self-administration will further expand the auto injectors market.

Restraints/Challenges Global Auto Injectors Market

On the other hand, increase in the preference for alternative drug delivery modes and development of nasal epinephrine sprays are expected to obstruct market growth. Also, development of autoinjectors for multiple drug viscosities and lack of proper training for using auto injectors are projected to challenge the auto injectors market in the forecast period of 2022-2029.

This auto injectors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on auto injectors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Auto Injectors Market

The medical services such as targeted therapies witnessed decline in revenues in the years 2020 and 2021 due to the outbreak of COVID-19. Major medical procedures were declined during the pandemic in order to prevent the risk of spreading coronavirus. However, rise in the self-administration procedures is expected in the post-COVID owing to the easing of restrictions.

Recent Development

  • Antares Pharma (US) made an agreement with Lunatus Global Medical Supplies (Dubai) in August’2020. Antares is expected to supply packaged products to Lunatus according to the agreement. Lunatus will submit and obtain regulatory approval for XYOSTED in the UAE and Saudi Arabia, and will promote, market and distribute XYOSTED in these two countries.

Global Auto Injectors Market Scope and Market Size

The auto injectors market is segmented on the basis of therapy, type, end- users, route of administration, molecule, design and product. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Therapy

  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Anaphylaxis
  • Other Therapies

On the basis of therapy, the auto injectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis and other therapies.

Type

  • Disposable Auto Injectors
  • Reusable Auto Injectors

Auto injectors market on the basis of type is segmented into disposable auto injectors and reusable auto injectors. Reusable auto injector is further divided into prefilled and empty.

End- Users

  • Home Care Settings
  • Hospitals and Clinics
  • Ambulatory Surgical Centers

Based on end- users, the auto injectors market is divided into home care settings, hospitals and clinics, and ambulatory surgical centers.

Route of Administration

  • Subcutaneous
  • Intramuscular

On the basis of route of administration, the auto injectors market is segmented into subcutaneous and intramuscular.

Type of Molecule

  • Monoclonal Antibody
  • Peptide
  • Protein
  • Small Molecule

On the basis of type of molecule, the auto injectors market is segmented into monoclonal antibody, peptide, protein, and small molecule.

Design

  • Standardized
  • Customized

Design segment of the auto injector market is divided into standardized and customized.

Product

  • Prefilled
  • Fillable

On the basis of product, the auto injector market is segmented into prefilled and fillable.

Auto Injectors Market Regional Analysis/Insights

The auto injector market is analysed and market size insights and trends are provided by country, therapy, type, end- users, route of administration, type of molecule, design and product as referenced above.

The countries covered in the auto injector market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the auto injector market because of the advancements in medical devices technologies and advanced healthcare infrastructure within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increasing incidence of diabetics and anaphylaxis due to food allergies in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The auto injector market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for auto injector market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the auto injector market. The data is available for historic period 2010-2020.

Competitive Landscape and Auto Injectors Market Share Analysis

The auto injector market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to auto injector market.

Some of the major players operating in the auto injector market are AbbVie Inc. (US), Mylan N.V. (US), Lily. (US), Amgen Inc. (US), Ypsomed Holding (Switzerland), BD (US), Owen Mumford Ltd. (UK), Consort Medical, Plc. (UK), SHL Medical AG (Switzerland), Johnson Medtech, LLC. (US), Teva Pharmaceuticals USA, Inc. (US), Antares Pharma. (New Jersey), AstraZeneca (UK), Union Medico Inc. (Denmark), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc (US), and Emergent. (US), among others.

Research Methodology : Global Auto Injectors Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-auto-injectors-market


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Auto Injectors Market will be projected at USD 270.78 billion during the forecast period of 2022 to 2029.
The Auto Injectors Market is Expected to Witness CAGR of 21.77% During the Forecast Period of 2022 to 2029.
The Major Players Operating in the Auto Injectors Market are AbbVie Inc. (US), Mylan N.V. (US), Lily. (US), Amgen Inc. (US), Ypsomed Holding (Switzerland), BD (US), Owen Mumford Ltd. (UK), Consort Medical, Plc. (UK), SHL Medical AG (Switzerland), Johnson Medtech, LLC. (US), Teva Pharmaceuticals USA, Inc. (US), Antares Pharma. (New Jersey), among others.
The Countries Covered in the Auto Injector Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Auto Injectors Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials